TWA
ALNY icon

TCI Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

TCI Wealth Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-38
Closed -$7.61K – 284
2023
Q1 		$7.61K Buy
38
+9
+31% +$1.89K ﹤0.01% 1247
2022
Q4 		$6.89K Buy
29
+25
+625% +$5.33K ﹤0.01% 1321
2022
Q3 		$1K Buy
4
+1
+33% +$191 ﹤0.01% 2022
2022
Q2 		$0 Hold
3
– – ﹤0.01% 2257
2022
Q1 		$0 Sell
3
-1
-25% -$152 ﹤0.01% 2207
2021
Q4 		$1K Sell
4
-35
-90% -$6.5K ﹤0.01% 2150
2021
Q3 		$7K Buy
39
+36
+1,200% +$6.75K ﹤0.01% 1327
2021
Q2 		$1K Sell
3
-21
-88% -$3.08K ﹤0.01% 2170
2021
Q1 		$3K Buy
24
+19
+380% +$2.86K ﹤0.01% 1478
2020
Q4 		$1K Hold
5
– – ﹤0.01% 1321
2020
Q3 		$1K Hold
5
– – ﹤0.01% 1249
2020
Q2 		$1K Sell
5
-10
-67% -$1.35K ﹤0.01% 1192
2020
Q1 		$2K Buy
15
+5
+50% +$577 ﹤0.01% 968
2019
Q4 		$1K Sell
10
-1
-9% -$100 ﹤0.01% 1271
2019
Q3 		$1K Hold
11
– – ﹤0.01% 1212
2019
Q2 		$1K Sell
11
-8
-42% -$614 ﹤0.01% 1128
2019
Q1 		$2K Buy
19
+8
+73% +$669 ﹤0.01% 988
2018
Q4 		$1K Sell
11
-7
-39% -$538 ﹤0.01% 1131
2018
Q3 		$2K Buy
18
+7
+64% +$704 ﹤0.01% 991
2018
Q2 		$1K Hold
11
– – ﹤0.01% 1228
2018
Q1 		$1K Hold
11
– – ﹤0.01% 1075
2017
Q4 		$1K Hold
11
– – ﹤0.01% 1126
2017
Q3 		$1K Hold
11
– – ﹤0.01% 1053
2017
Q2 		$1K Buy
+11
New +$703 ﹤0.01% 1081
2017
Q1 		– Sell
-9
Closed – – 1279
2016
Q4 		$0 Hold
9
– – ﹤0.01% 1346
2016
Q3 		$1K Buy
+9
New +$635 ﹤0.01% 1066

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TCI Wealth Advisors's ALNY Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2023, closing a stake of 38 shares — an estimated $7.61K sold.

TCI Wealth Advisors first reported a position in ALNY in Q3 2016 and held it in 26 quarters. The position peaked at $7.61K in Q1 2023. 476 funds tracked by Wall St. Rank hold ALNY as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Alnylam Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 38 Alnylam Pharmaceuticals shares in Q2 2023, an estimated $7.61K.
  • TCI Wealth Advisors first reported a position in Alnylam Pharmaceuticals in Q3 2016 and held it in 26 quarters.
  • TCI Wealth Advisors's Alnylam Pharmaceuticals position peaked at $7.61K in Q1 2023.
  • 476 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.